Atlas Trials

Central Institute of Epidemiology, Moscow, Russia

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Central Institute of Epidemiology, Moscow, Russia

RecordFirmDate
Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients (NCT01059422)Central Institute of Epidemiology, Moscow, Russia2010-10-01

Track Central Institute of Epidemiology, Moscow, Russia automatically

Every clearance here is in the API, with alerts when new ones post.